Reported Jan 29, 2014 · Terminated
glyBURIDE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093834301.
Aidapak Services, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Aidapak Services, LLC · 14301 Se 1st St · Vancouver, WA · 98684-3501
Is this the product you have?
- glyBURIDE, Tablet, 2.5 mg, Rx only
- Distributed byAidaPak Service, LLC, NDC 00093834301
- Lot codes and dates
- glyBURIDE, Tablet, 2.5
- mg has the following codesPedigree: AD46265_22
- EXP5/15/2014
- PedigreeW003688
- EXP5/31/2014
- PedigreeAD21790_55
- EXP5/1/2014
- PedigreeAD30140_34
- EXP5/7/2014
- Amount recalled
- 500 Tablets
This recall covers 265 products
The agency filed one notice per product. You are reading one of them; the other 264 are below.
252 more are in the archive.
Where it was sold
Why it was recalled
Labeling: Label Mixup: glyBURIDE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs: sulfaSALAzine, Tablet, 500 mg, NDC 59762500001, Pedigree: AD46265_13, EXP: 5/15/2014; ENTECAVIR, Tablet, 0.5 mg, NDC 00003161112, Pedigree: W003687, EXP: 6/26/2014; RALTEGRAVIR, Tablet, 400 mg, NDC 00006022761, Pedigree: AD21790_22, EXP: 5/1/2014; carBAMazepine ER, Tablet, 100 m
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Aidapak Services, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.